Article
Novel mutations in Myoclonin1/EFHC1 in sporadic and familial juvenile myoclonic epilepsy.
Neurology - 27 May 2008
Medina M T, Suzuki T, Alonso M E, Durón R M, Martínez-Juárez I E, Bailey J N, Bai D, Inoue Y, Yoshimura I, Kaneko S, Montoya M C, Ochoa A, Prado A Jara, Tanaka M, Machado-Salas J, Fujimoto S, Ito M, Hamano S, Sugita K, Ueda Y, Osawa M, Oguni H, Rubio-Donnadieu F, Yamakawa K, Delgado-Escueta A V
Abstract excerpt
BACKGROUND: Juvenile myoclonic epilepsy (JME) accounts for 3 to 12% of all epilepsies. In 2004, the GENESS Consortium demonstrated four missense mutations in Myoclonin1/EFHC1 of chromosome 6p12.1 segregating in 20% of Hispanic families with JME. OBJECTIVE: To examine what percentage of consecutive JME clinic cases have mutations in Myoclonin1/EFHC1. METHODS: We screened 44 consecutive patients from Mexico and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
